Dextroamphetamine Sulfate
44 NDCs across 14 manufacturers|40 Generic,4 Brand
Dextroamphetamine Sulfate is used to treat attention deficit disorder with hyperactivity and narcolepsy, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved before 1982, and the first generic was approved Jan 1, 1982. FDA's Orange Book lists 9 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $10 million on Dextroamphetamine Sulfate across 97,000 claims for 16,000 beneficiaries.
Dextroamphetamine Sulfate is available as 44 NDCs from 14 manufacturers (40 generic, 4 brand), with NADAC prices from $0.37 to $22.40 per EA — the most expensive product costs about 60× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
44
40G / 4B
Manufacturers
14
competing in market
Price Spread
$0.37 – $22.40
per EA, 42 of 44 NDCs
7d Activity
avg +2.5% WoW · of 44 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
Wilshire Pharmaceuticals Inc. manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Lead class
Central Nervous System Stimulant class view
See how this market rolls up into the broader therapeutic class and compare other drugs in the same bucket.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
14 manufacturers producing DEXTROAMPHETAMINE SULFATE(2 pricing outliers)
Frequently Asked Questions
What is Dextroamphetamine Sulfate used to treat?
Dextroamphetamine Sulfate is used to treat attention deficit disorder with hyperactivity and narcolepsy, per the National Library of Medicine's MED-RT classification.
When did Dextroamphetamine Sulfate become available as a generic?
FDA approved the first generic Dextroamphetamine Sulfate (ANDA) on Jan 1, 1982. The Orange Book currently lists 9 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Dextroamphetamine Sulfate?
In 2024, Medicare Part D spent $10 million on Dextroamphetamine Sulfate across 97,000 claims for 16,000 beneficiaries.
How many Dextroamphetamine Sulfate products are on the market?
The Dextroamphetamine Sulfate drug market contains 44 NDCs from 14 manufacturers — 40 generic and 4 brand products.
What is the price range for Dextroamphetamine Sulfate?
NADAC reference prices for Dextroamphetamine Sulfate range from $0.3729 to $22.4010 per EA — the most expensive product costs about 60× the cheapest. 2 additional products are priced per different units (e.g. liquids per ML) and aren't directly comparable.
Is generic Dextroamphetamine Sulfate cheaper than brand?
The average generic NADAC for Dextroamphetamine Sulfate is $1.7655 per EA, versus $13.2819 for brand-labeled products — brand versions average about 7.5× the generic price.
Which manufacturers make Dextroamphetamine Sulfate?
14 manufacturers list Dextroamphetamine Sulfate in NADAC. Ranked by number of NDCs, the largest are Wilshire Pharmaceuticals Inc. (7), Winder Laboratories LLC (7), KVK-Tech Inc. (6), SpecGx LLC (5), Amneal Pharmaceuticals of New York LLC (3).
How has the price of Dextroamphetamine Sulfate changed recently?
Over the past 7 days, 17 Dextroamphetamine Sulfate NDCs rose and 15 fell, with a market-wide average change of +2.5%.